Please cascade within your department/centre/organization.
In this week’s issue:
- BrightFocus Foundation – Macular Degeneration Research (final reminder)
- Glaucoma Research Foundation – 2014 Research Projects
- Michael Smith Foundation for Health Research – 2014 Health Services & Policy Research Support Network Partnership Program
- Prostate Cancer Foundation – Global Treatment Sciences Challenge Award
Awards and Honours:
- Michael Smith Foundation for Health Research – Aubrey J. Tingle Prize
LOI Deadline: July 31, 2014
The BrightFocus Foundation is currently accepting proposals to the Macular Degeneration Research program. Full applications are to be submitted by invitation only and are due November 18, 2014.
Applicants must first submit a Letter of Intent, which is due July 31, 2014. BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of age-related macular degeneration.
The maximum award value is US $80,000, per year, payable over two years (total value $160,000). All submitted proposals are subjected to peer-review by a qualified Scientific Review Committee, consisting of active academic and clinical researchers from within the macular degeneration research field.
Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Typically these awards are made to junior investigators, or to more established investigators who are proposing particularly innovative research.
For application instructions and information about our programs, please visit the BrightFocus Foundation website.
LOI Deadline: July 31, 2014
Founded in 1978, the San Francisco-based Glaucoma Research Foundation was created to encourage innovative research to find better ways to care for people with glaucoma—the leading cause of preventable blindness.
Through its Shaffer Grants program, the foundation will award one-year, $40,000 grants in support of innovative, high-impact clinical, epidemiological, and laboratory research projects designed to finding better ways to care for people with glaucoma. The grants do not support equipment exceeding $12,000, salaries for principal investigators and co-investigators, projects with overt commercial applications, lab supplies, or indirect costs.
Preliminary proposals must be received no later than July 31, 2014. Upon review, selected applicants will receive an e-mail with instructions for completing and submitting a full online grant application, which will be due on September 30, 2014.
To be eligible, applicants must possess at least a graduate degree. Interdisciplinary teams and collaborations that may lead to new glaucoma treatments are encouraged.
See the Glaucoma Research Foundation website for complete program guidelines and application instructions, as well as a list of previous Shaffer grant recipients.
Deadline: September 3, 2014, 4:30pm PST
The HSPRSN Partnership Program supports BC researchers applying for peer-reviewed, national or international team or operating grant competitions, which address BC health services and policy research priorities and which require researchers to acquire matching funds as a condition of award.
The HSPRSN Partnership Program will provide successful applicants to competitions launched in 2014 with matching funds of up to a maximum of $80,000 per project over the duration of the award term, provided the application meets the eligibility criteria as outlined in the competition guidelines.
Application guidelines are available at the MSFHR website.
Deadline: September 22, 2014
The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for lethal prostate cancer. Approximately 5-10 GTSN Challenge Awards will be funded depending on level of innovation in applications received. High risk, first-in-field and currently unfunded projects are most desired.
PCF Challenge Awards support large-scale team science research projects concerning lethal prostate cancer over the duration of 2-3 years, provide up to a total of $1,000,000 per team and cover direct research costs only.
This award will support the correlative research around either clinical trials of novel agents or strategies of standard of care. One emphasis is on developing or validating biomarkers that guide therapy in patients or further our understanding of the mechanism by which therapies work. While the focus is on research in humans, the actual trials or treatments themselves will not be supported. Human samples are highly preferred, although at times, model systems might be required to complement the understanding of an important mechanism.
Please refer to the RFA for details on eligibility requirements and application submission guidelines.
AWARDS AND HONOURS:
Nomination deadline: September 5, 2014
The Aubrey J. Tingle Prize is awarded annually to a British Columbia clinician scientist or scholar practitioner whose work in health research is internationally recognized and has had a significant impact on improving health and the health system.
The prize was created to honour Dr. Aubrey J. Tingle’s important contributions to BC health research as founding president & CEO of the Michael Smith Foundation for Health Research. A pediatrician and an immunologist, Dr. Tingle has maintained a lifelong interest in the role of viruses in disease, with particular interest in rubella, arthritis, and the possible viral causes of juvenile diabetes.
The prize is valued at $10,000. The prize winner will be invited to present at an MSFHR event.
To submit a nomination, please refer to the MSFHR website.